Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Maxwell Technologies Inc.
NEW YORK, March 8, 2013 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Maxwell Technologies Inc. ("Maxwell Technologies" or the "Company") (NasdaqGS: MXWL). The investigation focuses on whether the Company and certain of its former executives violated federal securities laws.
On March 8, 2013 shares of Maxwell Technologies fell over 10% in early morning trading after the Company announced that previously issued financial statements contained in its annual report on Form 10-K for the year ended December 31, 2011, and all unaudited quarterly reports on Form 10-Q in 2011 and 2012, respectfully, should no longer be relied upon because of errors in those financial statements. According to the Company, the errors relate to the timing of recognition of revenue from sales to certain distributors. The investigation discovered arrangements with certain distributors regarding the payment terms for sales to such distributors with respect to certain transactions. These arrangements had not been communicated to Maxwell's finance and accounting department and, therefore, had not been considered when recording revenue on shipments to these distributors. As a result of the investigation, certain employees were terminated and Maxwell's Sr. Vice President of Sales and Marketing resigned.
If you are aware of any facts relating to this investigation, or purchased shares Maxwell Technologies, you can assist this investigation by contacting either Peretz Bronstein or Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email firstname.lastname@example.org. Those who inquire by e-mail are encouraged to include their mailing address and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman , 212-697-6484
SOURCE Bronstein, Gewirtz & Grossman, LLC
More by this Source
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc.
May 22, 2013, 16:05 ET
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of iGATE Corporation
May 22, 2013, 08:30 ET
Bronstein, Gewirtz & Grossman, LLC Notifies Investors with Losses on Their Investment in Accretive Health, Inc. of Class Action Lawsuit and the Deadline to Seek a Lead Plaintiff Position
May 21, 2013, 16:05 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.